Elite in Type 2 Diabetes (T2D)

Dr. Neda Rasouli

Endocrinology
Uchealth Concussion Multidisciplinary Clinic-Anschutz Medical Campus
1635 Aurora Ct Fl 6, 
Aurora, CO 
27 Years of Experience
Elite in Type 2 Diabetes (T2D)
Uchealth Concussion Multidisciplinary Clinic-Anschutz Medical Campus
1635 Aurora Ct Fl 6, 
Aurora, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neda Rasouli is an Endocrinologist in Aurora, Colorado. Dr. Rasouli has been practicing medicine for over 27 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Low Blood Sugar.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 45 articles and participated in 5 clinical trials in the study of Type 2 Diabetes (T2D).

Specialties
Endocrinology
Licenses
Internal Medicine in CO
Hospital Affiliations
University Of Colorado Hospital Authority
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Uchealth Concussion Multidisciplinary Clinic-Anschutz Medical Campus
1635 Aurora Ct Fl 6, Aurora, CO 80045
Call: 720-848-2650
Other Locations
Denver Veterans Administration
1055 Clermont St, Denver, CO 80220
Call: 303-399-8020

Additional Areas of Focus

Dr. Rasouli has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications: An Adaptive Implementation Study
Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications: An Adaptive Implementation Study
Enrollment Status: Completed
Publish Date: March 20, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Enrollment Status: Completed
Publish Date: April 14, 2022
Intervention Type: Drug
Study Drugs: Glimepiride, Sitagliptin, Liraglutide, Insulin (glargine)
Study Phase: Phase 3
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 20, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

70 Total Publications

Enabling reproducible type 1 diabetes polygenic risk scoring for clinical and translational applications.
Enabling reproducible type 1 diabetes polygenic risk scoring for clinical and translational applications.
Journal: medRxiv : the preprint server for health sciences
Published: August 12, 2025
View All 70 Publications
Similar Doctors
Distinguished in Type 2 Diabetes (T2D)
Dr. Satish Garg
Endocrinology
Distinguished in Type 2 Diabetes (T2D)
Dr. Satish Garg
Endocrinology

Laboratory Corporation Of America

1775 Aurora Ct, 
Aurora, CO 
 (0.1 miles away)
303-724-1923
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Satish Garg is an Endocrinologist in Aurora, Colorado. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Diabetic Ketoacidosis.

Distinguished in Type 2 Diabetes (T2D)
Dr. Leigh Perreault
Endocrinology
Distinguished in Type 2 Diabetes (T2D)
Dr. Leigh Perreault
Endocrinology

University Of Colorado Hospital Authority

7403 Church Ranch Blvd Unit 107, 
Broomfield, CO 
 (17.7 miles away)
720-516-3063
Languages Spoken:
English
See accepted insurances

Leigh Perreault is an Endocrinologist in Broomfield, Colorado. Dr. Perreault is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Obesity, Maturity Onset Diabetes of the Young, and Multiple Endocrine Neoplasia Type 2.

Distinguished in Type 2 Diabetes (T2D)
Dr. Michael Mcdermott
Endocrinology
Distinguished in Type 2 Diabetes (T2D)
Dr. Michael Mcdermott
Endocrinology

University Of Colorado Hospital

1665 Aurora Ct Fl 2, 
Aurora, CO 
 (0.4 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Mcdermott is an Endocrinologist in Aurora, Colorado. Dr. Mcdermott is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Osteoporosis.

VIEW MORE TYPE 2 DIABETES (T2D) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rasouli's expertise for a condition
ConditionClose
  • Elite
  • Type 2 Diabetes (T2D)
    Dr. Rasouli is
    Elite
    . Learn about Type 2 Diabetes (T2D).
    See more Type 2 Diabetes (T2D) experts
  • Distinguished
  • Maturity Onset Diabetes of the Young
    Dr. Rasouli is
    Distinguished
    . Learn about Maturity Onset Diabetes of the Young.
    See more Maturity Onset Diabetes of the Young experts
  • Advanced
  • Obesity
    Dr. Rasouli is
    Advanced
    . Learn about Obesity.
    See more Obesity experts
  • Experienced
  • Congenital Hyperinsulinism
    Dr. Rasouli is
    Experienced
    . Learn about Congenital Hyperinsulinism.
    See more Congenital Hyperinsulinism experts
  • Diabetic Ketoacidosis
    Dr. Rasouli is
    Experienced
    . Learn about Diabetic Ketoacidosis.
    See more Diabetic Ketoacidosis experts
  • Diabetic Nephropathy
    Dr. Rasouli is
    Experienced
    . Learn about Diabetic Nephropathy.
    See more Diabetic Nephropathy experts
  • Low Blood Sugar
    Dr. Rasouli is
    Experienced
    . Learn about Low Blood Sugar.
    See more Low Blood Sugar experts
  • Malnutrition
    Dr. Rasouli is
    Experienced
    . Learn about Malnutrition.
    See more Malnutrition experts
  • Rabson-Mendenhall Syndrome
    Dr. Rasouli is
    Experienced
    . Learn about Rabson-Mendenhall Syndrome.
    See more Rabson-Mendenhall Syndrome experts
View All 7 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.